CRL  valuation analysis

Basics
Name: Charles River Laboratories International, Inc
Description: Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. (more)
Industry: Diagnostics & Research
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 04, 2021
Market cap: $17.73B (234th)
Sales(TTM): $3.04B (365th)
Earnings(TTM): $378.40M (303rd)

Value
FFER: 2.22 (why)
Actual price: $353.08
FFEThis is Charles River Laboratories International, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $152.27
Quantile: CRL is very expensive given its fundamentals.
Prices as of EOD 2021-06-16
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Charles River Laboratories International, Inc
"Diagnostics & Research" industry
Sales / MarketCap
Charles River Laboratories International, Inc
"Diagnostics & Research" industry
Book / MarketCap
Charles River Laboratories International, Inc
"Diagnostics & Research" industry
Equity / Assets
Charles River Laboratories International, Inc
"Diagnostics & Research" industry